NCT00306969View on ClinicalTrials.gov

Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

April 30, 2004

Conditions

Cutaneous T-Cell Lymphoma

Interventions

DRUG

bexarotene

DEVICE

photopheresis

Trial Locations (1)

02118

Boston University Medical Center, Boston

Sponsors

Collaborators (1)

Ligand Pharmaceuticals

All Listed Sponsors

collaborator

Ligand Pharmaceuticals

INDUSTRY

lead

Boston University

OTHER

NCT00306969 - Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma | Biotech Hunter | Biotech Hunter